Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

Nature

Volumn 393, Issue 6680, 1998, Pages 83-85

  Qiu, Yun ^a   Ravi, Lakshmeswari ^a   Kung, Hsing Jien ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; ENZYME ACTIVATION; IMMUNE RESPONSE; INFLAMMATION; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0032492879     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/30012     Document Type: Article

References (24)

1. Hirano, T. The biology of interleukin-6. Chem. Immunol. 51, 153-180 (1992).
2. Siegsmund, M. J., Yamazaki, H. & Pastan, I. Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia. J. Urol. 151, 1396-1399 (1994).
3. Hutchins, D. & Steel, C. M. Regulation of ICAM-1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast-derived factors. Int. J. Cancer 58, 80-84 (1994).
4. Okamoto, M., Lee, C. & Oyasu, R. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res. 57, 141-146 (1997).
5. Myers, R. B., Srivastava, S., Oelschlager, D. K. & Grizzle, W. E. Expression of p160erB-3 and p185 erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. J. Nat. Cancer Inst. 86, 1140-1145 (1994).
6. Zhau, H. E. et al. Biomarkers associated with prostate cancer progression. J. Cell. Biochem. (Suppl.) 19, 208-216 (1994).
7. Grasso, A., Wen, D., Pretlow, T. & Kung, H. ErbB kinases and NDF signaling in prostate cancer cells. Oncogene 15, 2705-2717 (1997).
8. Holmes, W. E. et al. Identification of heregulin, a specific activator of p185erbB2. Science 256, 1205-1210 (1992).
9. Wen, D. et al. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell 69, 559-572 (1992).
10. Dougall, W. C. et al. The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 9, 2109-2123 (1994).
11. Levitzki, A. & Gazit, A. Tyrosine kinase inhibition: an approach to drug development. Science 267, 1782-1788 (1995).
12. Beerli, R. R., Wels, W. & Hynes, N. E. Intracellutar expression of single chain antibodies reverts ErbB-2 transformation. J. Biol. Chem. 269, 23931-23936 (1994).
13. Carraway, K. L. R. & Cantley, L. C. A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 78, 5-8 (1994).
14. Guy, P. M., Platko, J. V., Cantley, L. C., Cerione, R. A. & Carraway, K. L. R. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc. Natl Acad. Sci. USA 91, 8132-8136 (1994).
15. Kishimoto, T., Taga, T. & Akira, S. Cytokine signal transduction. Cell 76, 253-262 (1994).
16. Taniguchi, T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268, 251-255 (1995).
17. Chen-Kiang, S. Regulation of terminal differentiation of human B-cells by IL-6. Curr. Topics Microbiol. Immunol. 194, 189-198 (1995).
18. Fukada, T. et al. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 5, 449-460 (1996).
19. Siegall, C. B., Schwab, G., Nordan, R. P., FitzGerald, D. J. & Pastan, I. Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res. 50, 7786-7778 (1990).
20. Carpenter, G. & Cohen, S. Epidermal growth factor. J. Biol. Chem. 265, 7709-7712 (1990).
21. Rosette, C. & Karin, M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274, 1194-1197 (1996).
22. Daub, H., Weiss, F. U., Wallasch, C. & Ullrich, A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379, 557-560 (1996).
23. Yamauchi, T. et al. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390, 91-96 (1997).
24. Rui, H., Kirken, R. A. & Farrar, W. L. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J. Biol. Chem. 269, 5364-5368 (1994).